Immediate Insulin Dose Escalation Required
With blood glucose persistently in the 300s mg/dL on your current regimen, you need aggressive upward titration of both your basal (Toujeo) and prandial (Novolog) insulin doses, with increases every 3-4 days until glucose targets are achieved. 1
Why Your Current Doses Are Insufficient
Your total daily insulin dose is currently 125 units (65 units Toujeo + 60 units Novolog). With glucose levels persistently around 300 mg/dL, this represents significant underdosing. The 2025 ADA guidelines explicitly state that blood glucose ≥300 mg/dL requires insulin as first-line therapy and aggressive titration 1.
Specific Titration Strategy
Basal Insulin (Toujeo) Adjustment
Increase your Toujeo dose by 4-6 units every 3 days until fasting glucose reaches 100-130 mg/dL 1, 2. The guideline-recommended algorithm is:
- If fasting glucose >180 mg/dL (10 mmol/L): increase by 6-8 units
- If fasting glucose 140-180 mg/dL: increase by 4 units
- If fasting glucose 120-140 mg/dL: increase by 2 units
- Target: fasting glucose <100 mg/dL 1
Important caveat: Toujeo (U-300) requires approximately 10-20% higher doses than standard insulin glargine (U-100) to achieve equivalent glycemic control 2, 3. Your 65 units may be functionally equivalent to only 52-58 units of standard basal insulin.
Prandial Insulin (Novolog) Adjustment
Your 20 units TID is likely insufficient. Increase each mealtime dose by 2-3 units (10-15% increase) every 3 days based on 2-hour post-meal glucose readings 1:
- Target post-meal glucose: <180 mg/dL
- If post-meal glucose >250 mg/dL: increase that meal's dose by 3-4 units
- If post-meal glucose 180-250 mg/dL: increase by 2 units
- Adjust each meal dose independently based on its corresponding post-meal reading
Critical Monitoring Requirements
- Check fasting glucose daily to guide Toujeo adjustments
- Check pre-meal and 2-hour post-meal glucose to guide Novolog adjustments
- Do not wait for your next clinic visit—these adjustments should happen every 3-4 days 1, 2
- Monitor for hypoglycemia, though this is unlikely given your current hyperglycemia
Consider Adding GLP-1 Receptor Agonist
If you're not already on a GLP-1 RA (like semaglutide, dulaglutide), adding one should be strongly considered 1. The guidelines explicitly recommend GLP-1 RAs in combination with insulin when A1C remains above goal. This can:
- Reduce insulin requirements by 20-30%
- Provide additional A1C reduction of 1-1.5%
- Cause weight loss rather than the weight gain typical with insulin escalation
- Lower hypoglycemia risk compared to insulin alone 4
Common Pitfalls to Avoid
Therapeutic inertia is your enemy here. The guidelines emphasize reassessing and modifying therapy every 3-6 months, but with glucose at 300 mg/dL, you need changes every 3-4 days 1.
Don't undertitrate out of fear of hypoglycemia—with glucose this elevated, aggressive dose increases are both safe and necessary. Research shows weekly insulin adjustments based solely on glucose readings are safe and effective, with low rates of severe hypoglycemia 5.
Toujeo requires higher doses than you might expect due to its concentrated formulation (U-300 vs U-100). Don't be surprised if you need 80-100+ units of Toujeo to achieve adequate basal coverage 2, 3.
Expected Outcomes
With proper titration, you should see:
- Fasting glucose drop to 100-130 mg/dL within 2-3 weeks
- Post-meal glucose <180 mg/dL within 3-4 weeks
- A1C reduction of 1.5-2.5% over 12 weeks 6, 7
- Total daily insulin dose likely increasing to 150-200+ units
Bottom line: Your current doses are grossly inadequate for glucose levels of 300 mg/dL. Increase Toujeo by 6-8 units every 3 days and each Novolog dose by 2-3 units every 3 days until targets are met, and strongly consider adding a GLP-1 RA.